ArtVentive Medical Group

What ArtVentive Medical Group does

ArtVentive Medical Group, Inc. is a privately held medical device corporation founded in 2009 and headquartered in San Marcos, California, that develops and commercializes catheter-based endoluminal occlusion devices for peripheral vascular embolization. The company's flagship product is the ArtVentive EOS Vascular Plug, a mechanical occlusion device built on a nitinol coil frame combined with a membrane, which enables immediate, complete vessel occlusion upon deployment rather than relying on the thrombotic clotting response required by traditional coil-based embolization products. The portfolio has expanded to include the next-generation EOS-X system (FDA-cleared March 2022, in full-scale production since 2023) with multiple sizes (5mm, 8mm, 11mm) and a compatible line of EOS guide catheters and delivery accessories.

The company's go-to-market model is hybrid: direct enterprise sales to US hospitals (with a Territory Sales Manager buildout across five US regions), and distributor partnerships across 15+ European countries plus Australia, New Zealand, and Israel. End-customers are interventional radiologists and vascular surgeons performing embolization in academic medical centers, university hospitals, and private clinics; cited clinical reference sites include Johns Hopkins Hospital (US), Erasmus University Medical Center (Netherlands), San Matteo Hospital in Pavia (Italy), and Medical University of Lublin (Poland). Revenue mechanics are purely transactional hardware sales of plugs and guide catheters, with pricing negotiated at the institutional procurement level and no publicly disclosed pricing. The company has accumulated a regulatory footprint spanning CE Mark (2013, extended 2018), FDA 510(k) clearances (2014, plus extensions for 11mm and EOS-X), Japanese approval (March 2022), and an ISO 13485 certification achieved with a perfect 100/100 audit score. Revenue is not publicly disclosed; the company went private in March 2017 by filing Form 15 with the SEC, and reported $10M in financing from a European financial group in 2011 as the most recent disclosed capital event.

Name

ArtVentive Medical Group

Legal name

ArtVentive Medical Group, Inc.

Website

https://artventivemedical.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

ArtVentive Medical Group develops and commercializes the EOS Endoluminal Occlusion System, a catheter-based vascular plug for peripheral embolization that achieves immediate vessel occlusion. It sells directly to US hospitals and through international distributors in Europe, Australia, New Zealand, and Israel, serving interventional radiologists and vascular surgeons.

Ownership category

akta.pro rank

Product category

Vascular Embolization Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

akta.pro secondary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

Keywords

• Vascular embolization devices
• Endoluminal occlusion systems
• Peripheral vascular plugs
• Minimally invasive medical devices
• Interventional radiology devices

Headquarters

HQ city

Carlsbad

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. EOS Vascular Plug Device Sales: One-time sale of medical devices (EOS Plugs and Guide Catheters) for peripheral vascular embolization procedures. Products sold directly to US hospitals and through international distributors.
2. EOS Demo Kit Sales: Sales of professional demonstration kits for sales presentations, containing deployed EOS Plug, bare nitinol coil, Guiding Catheter, EOS Handle, and 10cc syringe

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

ArtVentive Medical Group designs, manufactures, and commercializes catheter-based endoluminal occlusion devices (the EOS Vascular Plug and EOS-X system) for peripheral vascular embolization. The nitinol-coil-with-membrane devices provide immediate vessel occlusion at deployment and are sold as physical products to hospitals and clinics for use by interventional radiologists and vascular surgeons.

Product overview

ArtVentive Medical Group offers a family of endoluminal occlusion devices led by the EOS™ Vascular Plug and its newer EOS-X line. The core products consist of expandable nitinol-based vascular plugs (5mm, 8mm, and 11mm sizes) designed for immediate peripheral vessel occlusion, along with specialized delivery catheters and guide catheters. The system is sold to hospitals in the US via a direct sales team and in European countries, Israel, Australia, and New Zealand through international distributors. The company is preparing to enter Latin American markets while pursuing approvals in Korea, Japan, Vietnam, China, India, and Singapore.

Differentiator

Problem solved

Functional benefit

Brands

• ArtVentive EOS™ Plug: Endoluminal occlusion device for vascular embolization enabling minimally invasive, immediate occlusion of targeted veins, arteries and other lumens within the body.
• EOS™
• EOS-X
• Endoluminal Occlusion System (EOS™)

Products and services

• ArtVentive EOS Vascular Plug Flagship catheter-based endoluminal occlusion device with a nitinol coil-with-membrane design that provides immediate, complete, and permanent vessel occlusion upon deployment for peripheral vascular embolization procedures; intended for use by interventional radiologists and vascular surgeons in hospitals.
• EOS-X Endoluminal Occlusion System Next-generation endoluminal occlusion system comprising EOS PG1-5 (5mm), EOS PG1-8 (8mm), and EOS PG1-11 (11mm) plugs with corresponding guide catheters, providing an extended range of treatable vessels and reduced delivery profile for peripheral vascular embolization.
• EOS 6F Guide Catheter (EOS PSG1-6) 6 French guide catheter for delivery and deployment of 5mm and 8mm EOS Plugs; 0.067 inch inner diameter, 0.0082 inch outer diameter, 89 cm working length, 0.035 inch guidewire compatibility. Accessory for the EOS system sold to hospitals performing peripheral embolization.
• EOS 7.5F Guide Catheter (EOS PSG1-7.5) 7.5 French guide catheter for delivery and deployment of the 11mm EOS Plug; 0.082 inch inner diameter, 0.101 inch outer diameter, 89 cm working length, 0.035 inch guidewire compatibility. Accessory for the EOS system sold to hospitals.
• EOS Delivery Catheter Specialized catheter system compatible with guidewire and designed for precise placement and deployment of EOS vascular plugs in peripheral vasculature; sold to hospitals as part of the EOS peripheral embolization system.
• EOS Demo Kit Professional sales demonstration kit containing a deployed EOS Plug, a bare nitinol coil, Guiding Catheter, EOS Handle, and 10 cc syringe, used by sales representatives for physician presentations and training.

Quantifiable outcome

• 100% vessel occlusion rate across 1,600+ implantations
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core, regional and minor.

• European Distributor NetworkcoreChannel Partner/ Reseller/ Distributor · 23 April 2014Expanded European distributor network covering 15+ countries providing product training and support for commercialization of EOS products in the EU market
• INOVANZ Pty LtdcoreChannel Partner/ Reseller/ DistributorExclusive distributor for ArtVentive products in Australia. Contact: www.inovanz.com
• Thomy F.E., d.o.o.regionalChannel Partner/ Reseller/ DistributorRegional distributor for ArtVentive products in Bosnia Herzegovina, Croatia, Serbia, and Slovenia
• Medical Murray Inc.minorStrategic or Co-development PartnerManufacturing research and development agreement signed in August 2010. Medical Murray is ISO certified and FDA registered, providing specialty manufacturing services for medical device development.
• Northwest Clinical Research Group, Inc.minorImplementation/ SI/ Consulting PartnerStrategic agreement signed in September 2010 with internationally renowned regulatory, clinical and quality assurance consulting group to support regulatory compliance and clinical trial management.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Abbott: Abbott markets the Amplatzer Vascular Plug family, the most direct mechanistic competitor to ArtVentive's EOS for peripheral vascular occlusion/embolization procedures. Both compete head-to-head with interventional radiologists and vascular surgeons.
• Cook Medical: Cook Medical is a long-established supplier of embolization coils, vascular plugs, and related peripheral embolization devices. Competes with ArtVentive EOS for the same vascular surgeon and IR customers across similar indications.
• Penumbra: Penumbra sells a portfolio of neurovascular and peripheral embolization coils (Ruby, Penumbra Coil 400, POD) and liquid embolics targeting the same IR/interventional neuroradiology call point as ArtVentive EOS.
• Medtronic: Medtronic offers an extensive embolization portfolio including the MVP micro vascular plug (acquired with ev3), Axium detachable coils, and Onyx liquid embolic, competing directly with EOS in peripheral and neurovascular embolization.
• Boston Scientific: Boston Scientific markets the VortX and Interlock coil families (acquired from Novate) for vascular embolization. Targets the same hospital IR suites and competes with ArtVentive's EOS plug on similar peripheral indications.
• Terumo: Terumo's Azur/HydroCoil and microvascular plug product lines compete with EOS in peripheral and neurovascular embolization, often sold through the same procedural specialty call points.
• Stryker: Stryker (via its Neurovascular business including the former Target/Stryker coils) competes in vascular embolization. ArtVentive's customer base at university hospitals is shared with Stryker's neurovascular/interventional portfolio.
• Cerenovus (Johnson & Johnson MedTech): Cerenovus offers embolization coils and liquids for neurovascular and peripheral embolization, including products that overlap the EOS plug's use cases in AVM and other lesion embolization.
• Merit Medical: Merit Medical manufactures vascular occlusion and embolization products sold into the same interventional radiology channel. It is a relevant comparator for ArtVentive's plug-and-accessory sales model and procedural cross-selling approach.

Emerging players

• Shape Memory Medical: Shape Memory Medical is an emerging company developing shape-memory alloy-based embolization devices for peripheral and neurovascular use. Conceptually adjacent to ArtVentive's plug technology and targeting the same IR physician base, though at an earlier commercial stage.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/artventive-medical-group-inc-

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ArtVentive Medical Group